Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Askins, M. A.
Right arrow Articles by Moore, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Askins, M. A.
Right arrow Articles by Moore, B. D., III
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Preventing Neurocognitive Late Effects in Childhood Cancer Survivors

Martha A. Askins, PhD

Department of Pediatrics, Children's Cancer Hospital, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Bartlett D. Moore, III, PhD

Department of Pediatrics, Children's Cancer Hospital, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, bmoore{at}mdanderson.org

Neurocognitive late effects are common sequelae of cancer in children, especially in those who have undergone treatment for brain tumors or in those receiving prophylactic cranial radiation therapy to treat leukemia. Neurocognitive morbidity in attention, executive functioning, processing speed, working memory, and memory frequently occurs and contributes to declines in intellectual and academic abilities. Oncologists are faced with the challenge of using the most effective, often the most intense, therapy to achieve the primary goal of medical success, balanced with the desire to prevent adverse late effects. Not all children with similar diagnoses and treatment have identical neurocognitive outcomes; some do very poorly and some do well. Attention now turns to the reliable prediction of risk for poor outcomes and then, using risk-adapted therapy, to preserve neurocognitive function. Prevention of late effects through rehabilitative strategies, continuation of school, and pharmacotherapy will be explored.

Key Words: pediatric cancer • brain tumors • leukemia • neurocognitive late effects

References

  • Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2007.
  • Ries LAG, Reichman ME, Lewis DR, et al. Cancer survival and incidence from the surveillance, epidemiology, and end results (SEER) program. Oncologist. 2003;8:541-552.[Abstract/Free Full Text]
  • Reddick WE, Russell JM, Glass JO, et al. Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn Reson Imaging. 2000;18:787-793.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Moore BD Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol. 2005;30:51-63.[Abstract/Free Full Text]
  • Butler RW, Mulhern RK Neurocognitive interventions for children and adolescents surviving cancer. J Pediatr Psychol. 2005;30:65-78.[Abstract/Free Full Text]
  • Palmer SL, Reddick WE, Gajjar A. Understanding the cognitive impact on children who are treated for medulloblastoma. J Pediatr Psychol. 2007;32:1040-1049.[Abstract/Free Full Text]
  • Fouladi M., Gilger E., Kocak M., et al. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol. 2005;23:7152-7160.[Abstract/Free Full Text]
  • Lahteenmaki PM, Harila-Saari A., Pukkala EI, et al. Scholastic achievements of children with brain tumors at the end of comprehensive education-A nationwide, register-based study. Neurology. 2007;69:296-305.[Abstract/Free Full Text]
  • Ater JL, van EJ, Woo SY, et al. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children. J Neurooncol. 1997;32:243-252.[CrossRef][Medline] [Order article via Infotrieve]
  • Mulhern RK, Hancock J., Fairclough D., Kun L. Neuropsychological status of children treated for brain-tumors: a critical-review and integrative analysis. Med Pediatr Oncol. 1992;20: 181-191.[Web of Science][Medline] [Order article via Infotrieve]
  • Mazzocco MM, Pennington BF, Hagerman RJ The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity. J Dev Behav Pediatr. 1993;14:328-335.[Web of Science][Medline] [Order article via Infotrieve]
  • Steen RG, Koury M., Granja CI, et al. Effect of ionizing radiation on the human brain: white matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2001;49:79-91.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mulhern RK, Palmer SL, Reddick WE, et al. Quantitative white matter loss explains risks of young age for neurocognitive deficits in medulloblastoma survivors. Arch Clin Neuropsychol. 2000;15:791-792.[Free Full Text]
  • Mulhern RK, Palmer SL, Reddick WE, et al. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol. 2001;19:472-479.[Abstract/Free Full Text]
  • Iuvone L., Mariotti P., Colosimo C., et al. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia. Cancer. 2002;95:2562-2570.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Netter FH Part I.: Anatomy and physiology: nervous system, vol 1. The CIBA Collection of Medical Illustrations. Summit, NJ: Ciba-Geigy Corporation; 1983.
  • Meyn RE, Milas L., Stephens C. Programmed cell death in normal development and disease. Cancer Bull. 1994;46:120-124.
  • Baron IS, Fennell EB, Voeller KKS. Neurodevelopmental and genetic syndromes. In: Pediatric Neuropsychology in the Medical Setting. New York, NY: Oxford University Press; 1995:64-113.
  • Wilson DA, Nitschke R., Bowman ME, et al. Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychological deficiencies. Radiology. 1991;180:205-209.[Abstract/Free Full Text]
  • Levin HS Neuroplasticity following non-penetrating traumatic brain injury. Brain Inj. 2003;17:665-674.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wolf H., Ecke GM, Bettin S., et al. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry. 2000;15:803-812.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schultheiss TE, Kun LE, Ang KK, Stephens LC Radiation response of the central nervous-system. Int J Radiat Oncol Biol Phys. 1995;31:1093-1112.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fouladi M., Langston J., Mulhern R., et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol. 2000;18:824-831.[Abstract/Free Full Text]
  • Lacaze E., Kieffer V., Streri A., et al. Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy. Br J Cancer. 2003;89:2038-2044.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Moore BD, Ater JL, Copeland DR Improved neuropsychological outcome in children with brain tumors diagnosed during infancy and treated without cranial irradiation. J Child Neurol. 1992;7:281-290.[Abstract/Free Full Text]
  • von der Weid N., Mosimann I., Hirt A., et al. Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences. Eur J Cancer. 2003;39:359-365.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol. 2000;15: 603-630.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Copeland DR, Moore BD, Francis DJ, et al. Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study. J Clin Oncol. 1996;14:2826-2835.[Abstract/Free Full Text]
  • Bleyer WA, Fallavollita J., Robison L., et al. Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: a report from the Children's Cancer Study Group. Pediatr Hematol Oncol. 1990;7:329-338.[Web of Science][Medline] [Order article via Infotrieve]
  • Balsom WR, Bleyer WA, Robison LL, et al. Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradation methotrexate? A Children's Cancer Study Group. Med Pediatr Oncol. 1991;19: 486-492.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Constine LS, Konski A., Ekholm S., et al. Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys. 1988;15:319-330.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Paakko E., Vainionpaa L., Lanning M., et al. White matter changes in children treated for acute lymphoblastic leukemia. Cancer. 1992;70:2728-2733.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Copeland DR, deMoor C., Moore BD III, Ater JL Neurocognitive development of children after a cerebellar tumor in infancy: a longitudinal study. J Clin Oncol. 1999;17:3476-3486.[Abstract/Free Full Text]
  • Radcliffe J., Bunin GR, Sutton LN, et al. Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: age-dependent effects of whole brain radiation. Int J Dev Neuroscience. 1994;12:327-334.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Walter AW, Mulhern RK, Gajjar A., et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol. 1999;17:3720-3728.[Abstract/Free Full Text]
  • Cichowski K., Shih TS, Schmitt E., et al. Mouse models of tumor development in neurofibromatosis type 1. Science. 1999;286: 2172-2176.[Abstract/Free Full Text]
  • Palmer SL, Gajjar A., Reddick WE, et al. Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma. Neuropsychology. 2003;17:548-555.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Anderson VA, Godber T., Smibert E., et al. Cognitive and academic outcome following cranial irradiation and chemotherapy in children: a longitudinal study. Br J Cancer. 2000;82: 255-262.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Spiegler BJ, Bouffet E., Greenberg ML, et al. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol. 2004;22:706-713.[Abstract/Free Full Text]
  • Ater JL, Moore BD, Francis DJ, et al. Correlation of medical and neurosurgical events with neuropsychological status in children at diagnosis of astrocytoma: utilization of a neurological severity score. J Child Neurol. 1996;11:462-469.[Abstract/Free Full Text]
  • Khong PL, Leung LH, Fung AS, et al. White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol. 2006;24:884-890.[Abstract/Free Full Text]
  • Mukherjee P. Diffusion tensor imaging and fiber tractography in acute stroke. Neuroimaging Clin N Am. 2005;15:655-665, xii. Review.
  • Wilde HE, McCauley S., Hunter JV, et al. Diffusion tensor imaging of acute mild traumatic brain injury in adolescents. Neurology. 2008;70:948-955.[Abstract/Free Full Text]
  • Krajinovic M., Robaey P., Chiasson S., et al. Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL. Pharmacogenomics. 2005;6:293-302.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Savitz J., Solms M., Ramesar R. The molecular genetics of cognition: dopamine, COMT and BDNF. Genes Brain Behav. 2006;5: 311-328.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mattay VS, Tessitore A., Callicott JH, et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol. 2002;51:156-164.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cools R., Stefanova E., Barker R., et al. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of prefrontal cortex and basal ganglia revealed by PET. Neuroimage. 2001;13:S652.[CrossRef][Web of Science]
  • Malhotra AK, Egan M., Lipsky RH, et al. The COMT Va1158Met polymorphism and human cognitive function. Biol Psychiatry. 2002;51:95S.
  • Malhotra AK, Kestler LJ, Mazzanti C., et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 2002;159:652-654.[Abstract/Free Full Text]
  • Bates JA, Goldman D., Malhotra AK COMT and neurocognition: new evidence for a role in visual memory. Schizophr Res. 2003;60:123.
  • de Frias CM, Annerbrink K., Westberg L., et al. COMT gene polymorphism is associated with declarative memory in adult-hood and old age. Behav Genet. 2004;34:533-539.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • de Frias CM, Annerbrink K., Westberg L., et al. COMT gene polymorphism is associated with cognitive functioning in adult-hood and old age. Behav Genet. 2004;34:635.
  • Kirsch DG, Tarbell NJ Conformal radiation therapy for childhood CNS tumors. Oncologist. 2004;9:442-450.[Abstract/Free Full Text]
  • Kirsch DG, Tarbell NJ New technologies in radiation therapy for pediatric brain tumors: the rationale for proton radiation therapy. Pediatr Blood Cancer. 2004;42:461-464.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Merchant TE, Mulhern RK, Krasin MJ, et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol. 2004;22:3156-3162.[Abstract/Free Full Text]
  • Schneider U., Lomax A., Lombriser N. Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation. Radiat Res. 2000;154:382-388.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Suit H. The Gray Lecture 2001: coming technical advances in radiation oncology. Int J Radiat Oncol Biol Phys. 2002;53:798-809.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Paganetti H., Niemierko A., Ancukiewicz M., et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53:407-421.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Doolittle ND, Anderson CP, Bleyer WA, et al. Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium. Neurooncol. 2001;3:46-54.[Abstract]
  • Mabbott DJ, Spiegler BJ, Greenberg ML, et al. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol. 2005;23:2256-2263.[Abstract/Free Full Text]
  • Baron I., Fennell EB, Voeller Kks. Pediatric Neuropsychology in the Medical Setting. New York, NY: Oxford University Press; 1995.
  • Searle NS, Askins M., Bleyer WA Adolescent cancer patients' perspectives on their educational experiences: ten case studies. Psychooncol. 2003;12:S78.[CrossRef]
  • Copeland DR, Askins MA Behavioral medicine in cancer care. Pediatric Oncology. In: Chan K, Raney RB, eds. New York, NY: Springer Science and Business Media, Inc; 2005:244-255.
  • Nathan PC, Patel SK, Dilley K., et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med. 2007;161:798-806.[Abstract/Free Full Text]
  • Butler RW Attentional processes and their remediation in childhood cancer. Med Pediatr Oncol. 1998;75-78.
  • Butler RW, Copeland DR Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc. 2002;8:115-124.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sohlberg MM, Mateer CA Improving attention and managing attentional problems. Adapting rehabilitation techniques to adults with ADD. Ann N Y Acad Sci. 2001;931:359-375.[Web of Science][Medline] [Order article via Infotrieve]
  • Meichenbaum D. Cognitive-Behavior Modification: An Integrative Approach. New York, NY: Plenum Press; 2008.
  • Mabbott DJ, Noseworthy MD, Bouffet E., et al. Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: correlation with IQ. Neurooncology. 2006;8: 244-252.[Abstract/Free Full Text]
  • Mulhern RK, White HA, Glass JO, et al. Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. J Int Neuropsychol Soc. 2004;10: 180-189.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Thompson SJ, Leigh L., Christensen R., et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol. 2001;19: 1802-1808.[Abstract/Free Full Text]
  • Mulhern RK, Khan R., Kaplan S., et al. A randomized, double-blind, placebo-controlled trial of methylphenidate for attentional problems in survivors of childhood cancer. J Clin Oncol. 2004;22:801S.[CrossRef]
  • Conklin HM, Khan RB, Reddick WE, et al. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol. 2007;32:1127-1139.[Abstract/Free Full Text]
  • Biederman J., Swanson JM, Wigal SB, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics. 2005;116:E777-E784.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rugino TA, Copley TC Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. J Am Acad Child Adolesc Psychiatry. 2001;40:230-235.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Child Neurology, Vol. 23, No. 10, 1160-1171 (2008)
DOI: 10.1177/0883073808321065
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
R. A. Brumback
Child Neurologists Should Be Interested In Brain Tumors!
J Child Neurol, November 1, 2009; 24(11): 1338 - 1340.
[PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Askins, M. A.
Right arrow Articles by Moore, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Askins, M. A.
Right arrow Articles by Moore, B. D., III
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?